Glenmark Pharmaceuticals Limited has informed the Exchange about Schedule of meet

Board & Shareholder Meetings View source PDF

GLENMARK · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+4.8%1-day move

₹2250.80

prior close

₹2268.10

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+2.4+2.3+2.9+3.2+4.8+5.9+1.9-2.1-3.2-3.1-4.1-4.5-2.3—

Up moveDown movePending

AI summary

Glenmark Pharmaceuticals has notified the exchanges about its Q4 FY 2026 Results Earnings Call scheduled for Monday, June 01, 2026 from 8:30 am to 9:30 am IST. The call will discuss the company's quarterly financial performance. Dial-in numbers have been provided for participants in India, USA, UK, Singapore, and Hong Kong. Pre-registration is also available online. The company will upload the recording on its website within 24 hours of the call. This is a routine investor engagement activity as part of the company's quarterly disclosure obligations.

Likely market impact

This announcement indicates Glenmark is on track to release its Q4 FY 2026 results soon, allowing investors to plan participation in the earnings call. No material financial information is disclosed in this filing, so there is no immediate impact on the stock. Investors seeking insights into the company's performance should mark their calendars for June 01, 2026.